Gilberto Lopes, MD, MBA, FAMS
Advertisement
Articles by Gilberto Lopes, MD, MBA, FAMS
Gilberto Lopes, MD, MBA, FAMS, discussed his presentation about when to stop immunotherapy treatments for patients with lung cancer.
Advertisement
Latest Updated Articles
32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose IntensityPublished: April 18th 2022 | Updated:
Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung CancerPublished: February 21st 2020 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
2
Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma
3
2026 Tandem Meetings: What’s the Latest Research in Multiple Myeloma?
4
Real World Outcomes of CAR T-Cell Therapy in Multiple Myeloma Including Older and Comorbid Patients
5